People In Brief
This article was originally published in The Gray Sheet
Executive Summary
FoxHollow loses CEO: President & CEO Robert Thomas resigns, effective Jan. 1. Thomas, who joined the SilverHawk plaque excision system manufacturer in 1998 and has been CEO since 2000, announced plans to retire Dec. 12. Founder and Chairman John Simpson steps in as interim CEO while the firm searches for a permanent replacement. The 44-year-old Thomas cited personal reasons for his departure, but some analysts question that explanation, according to reports in the Wall Street Journal. FoxHollow's stock has fallen sharply, closing Jan. 5 at $30.12, down 35% from $46.44 Dec. 9, the last trading day before the announcement...
You may also be interested in...
FoxHollow Stock Up 25% In Q3 On SilverHawk Profitability, Merck Deal
FoxHollow's stock advanced 25.1% in the third quarter as investors took notice of the firm's first profitable quarter, increased adoption of the company's SilverHawk peripheral vessel plaque excision system and an expanded research agreement with Merck
FoxHollow Stock Up 25% In Q3 On SilverHawk Profitability, Merck Deal
FoxHollow's stock advanced 25.1% in the third quarter as investors took notice of the firm's first profitable quarter, increased adoption of the company's SilverHawk peripheral vessel plaque excision system and an expanded research agreement with Merck
FoxHollow Delays Pursuit Of SilverHawk Coronary Artery Disease Indication
FoxHollow has once again delayed the start of a clinical trial to study the treatment of coronary artery disease with the SilverHawk plaque excision system